Savant Capital LLC Reduces Position in Cigna Group $CI

Posted by Brian Himes on Jun 1st, 2026

Savant Capital LLC lessened its holdings in shares of Cigna Group (NYSE:CI – Free Report) by 15.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,819 shares of the health services provider’s stock after selling 1,816 shares during the quarter. Savant Capital LLC’s holdings in Cigna Group were worth $2,703,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also modified their holdings of the business. Moors & Cabot Inc. boosted its stake in shares of Cigna Group by 1.1% during the 4th quarter. Moors & Cabot Inc. now owns 9,213 shares of the health services provider’s stock worth $2,536,000 after acquiring an additional 101 shares during the last quarter. Foundations Investment Advisors LLC boosted its stake in shares of Cigna Group by 12.2% during the 4th quarter. Foundations Investment Advisors LLC now owns 4,019 shares of the health services provider’s stock worth $1,106,000 after acquiring an additional 438 shares during the last quarter. Baker Avenue Asset Management LP purchased a new position in shares of Cigna Group during the 4th quarter worth $304,000. IFG Advisory LLC boosted its stake in shares of Cigna Group by 10.0% during the 4th quarter. IFG Advisory LLC now owns 9,810 shares of the health services provider’s stock worth $2,700,000 after acquiring an additional 890 shares during the last quarter. Finally, Huntington National Bank boosted its stake in shares of Cigna Group by 13.5% during the 4th quarter. Huntington National Bank now owns 8,568 shares of the health services provider’s stock worth $2,358,000 after acquiring an additional 1,022 shares during the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Down 0.1%

Shares of CI stock opened at $277.08 on Monday. The company has a market capitalization of $73.30 billion, a price-to-earnings ratio of 11.75, a PEG ratio of 1.00 and a beta of 0.28. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The company’s fifty day moving average price is $278.32 and its 200-day moving average price is $277.01. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The company’s revenue was up 4.6% on a year-over-year basis. During the same period last year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Sell-side analysts expect that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CI. Mizuho set a $330.00 price target on shares of Cigna Group in a research note on Friday, May 1st. The Goldman Sachs Group lifted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Barclays downgraded shares of Cigna Group from an “overweight” rating to an “equal weight” rating and decreased their price objective for the company from $310.00 to $304.00 in a research report on Tuesday, May 26th. Raymond James Financial set a $340.00 price objective on shares of Cigna Group in a research report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price objective for the company from $303.00 to $302.00 in a research report on Wednesday, May 20th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Cigna Group presently has an average rating of “Moderate Buy” and a consensus price target of $339.50.

Read Our Latest Report on CI

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the sale, the chief executive officer directly owned 34,337 shares in the company, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.